Ares-Serono interferon formulations
Executive Summary
Company's interferon product Frone (human fibroblast interferon) received approval in Italy for marketing in cream, injectable and eye drop forms. Indications include genital herpes, keratoconjunctivitis and condylomata. Drug is already marketed in Israel in cream form; Phase III clinicals are underway in U.S. under a limited partnership between Serono and Braintree Research Associates